SLC5A6
Basic information
Region (hg38): 2:27199587-27212958
Links
Phenotypes
GenCC
Source:
- inherited neurodegenerative disorder (Moderate), mode of inheritance: AR
- neurodegeneration, infantile-onset, biotin-responsive (Strong), mode of inheritance: AR
- neurodegeneration, infantile-onset, biotin-responsive (Moderate), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neurodegeneration, infantile-onset, biotin-responsive; Sodium-dependent multivitamin transporter deficiency | AR | Biochemical | Individuals with Neurodegeneration, infantile-onset, biotin-responsive may respond to biotin, as well as other medical treatments; Sodium-dependent multivitamin transporter deficiency is a multisystem metabolic disorder, and medical/dietary treatment (with biotin, pantothenic acid, and alpha-lipoic acid) has been shown to result in clinical improvement | Biochemical; Neurologic | 27904971; 31392107; 31754459; 35013551 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (3 variants)
- Neurodegeneration, infantile-onset, biotin-responsive (2 variants)
- Peripheral motor neuropathy, childhood-onset, biotin-responsive (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC5A6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 8 | |||||
missense | 37 | 13 | 53 | |||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 3 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 0 | |||||
non coding | 2 | |||||
Total | 4 | 6 | 38 | 17 | 6 |
Highest pathogenic variant AF is 0.00000657
Variants in SLC5A6
This is a list of pathogenic ClinVar variants found in the SLC5A6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-27200457-G-C | Inborn genetic diseases | Uncertain significance (Sep 06, 2022) | ||
2-27200464-G-T | Inborn genetic diseases | Uncertain significance (Apr 22, 2022) | ||
2-27200477-CCT-C | Neurodegeneration, infantile-onset, biotin-responsive • Peripheral motor neuropathy, childhood-onset, biotin-responsive | Likely pathogenic (Feb 08, 2023) | ||
2-27200999-T-C | Uncertain significance (Mar 03, 2024) | |||
2-27201024-G-A | Inborn genetic diseases | Uncertain significance (Jan 30, 2024) | ||
2-27201040-C-T | Benign (Dec 26, 2018) | |||
2-27201042-G-A | Inborn genetic diseases | Uncertain significance (Nov 14, 2023) | ||
2-27201088-G-T | Inborn genetic diseases | Uncertain significance (Aug 23, 2021) | ||
2-27201104-C-T | Neurodegeneration, infantile-onset, biotin-responsive | Likely benign (Aug 12, 2021) | ||
2-27201355-A-G | Inborn genetic diseases | Uncertain significance (Feb 28, 2024) | ||
2-27201359-G-C | Inborn genetic diseases | Likely benign (Dec 28, 2022) | ||
2-27201380-C-A | Inborn genetic diseases | Uncertain significance (Apr 05, 2023) | ||
2-27201437-G-A | Inborn genetic diseases | Likely benign (Mar 20, 2024) | ||
2-27201669-G-A | Inborn genetic diseases | Uncertain significance (Oct 10, 2023) | ||
2-27201709-C-T | Inborn genetic diseases | Uncertain significance (Sep 22, 2023) | ||
2-27201735-C-T | Benign (Dec 26, 2018) | |||
2-27201750-G-A | Inborn genetic diseases | Likely benign (Jan 04, 2022) | ||
2-27201755-G-C | Likely benign (Jun 13, 2018) | |||
2-27201768-G-A | Benign (Jul 02, 2020) | |||
2-27201771-C-T | Inborn genetic diseases | Uncertain significance (Jan 10, 2022) | ||
2-27201778-T-G | Inborn genetic diseases | Uncertain significance (Sep 12, 2023) | ||
2-27201784-C-T | Inborn genetic diseases | Uncertain significance (Nov 21, 2022) | ||
2-27201785-G-A | Benign (Jun 01, 2024) | |||
2-27201796-T-C | Inborn genetic diseases | Uncertain significance (Feb 21, 2024) | ||
2-27201796-T-G | Inborn genetic diseases | Uncertain significance (Nov 29, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC5A6 | protein_coding | protein_coding | ENST00000310574 | 15 | 13372 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00608 | 0.994 | 125699 | 0 | 49 | 125748 | 0.000195 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.63 | 291 | 380 | 0.765 | 0.0000219 | 4060 |
Missense in Polyphen | 72 | 135.16 | 0.53271 | 1405 | ||
Synonymous | 0.207 | 155 | 158 | 0.979 | 0.00000940 | 1385 |
Loss of Function | 3.61 | 10 | 32.0 | 0.312 | 0.00000175 | 326 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000296 | 0.000296 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000246 | 0.000246 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000196 | 0.000196 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Transports pantothenate, biotin and lipoate in the presence of sodium.;
- Pathway
- Vitamin digestion and absorption - Homo sapiens (human);Nuclear Receptors Meta-Pathway;NRF2 pathway;Biotin transport and metabolism;Vitamin B5 - CoA biosynthesis from pantothenate;Metabolism;Vitamin B5 (pantothenate) metabolism;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of small molecules;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors;Lipoate metabolism;Vitamin H (biotin) metabolism
(Consensus)
Intolerance Scores
- loftool
- 0.125
- rvis_EVS
- -0.09
- rvis_percentile_EVS
- 47.06
Haploinsufficiency Scores
- pHI
- 0.280
- hipred
- N
- hipred_score
- 0.476
- ghis
- 0.471
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.504
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc5a6
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); digestive/alimentary phenotype; limbs/digits/tail phenotype; skeleton phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- sodium ion transport;biotin transport;pantothenate transmembrane transport
- Cellular component
- plasma membrane;integral component of plasma membrane;vesicle membrane;membrane;brush border membrane
- Molecular function
- sodium-dependent multivitamin transmembrane transporter activity